Journal of Clinical Oncology, Vol 6, 18-25, Copyright © 1988 by American Society of Clinical Oncology

ARTICLES

Preliminary results of a randomized study of adjuvant radiation therapy in resectable adult retroperitoneal soft tissue sarcomas

TJ Kinsella, WF Sindelar, E Lack, E Glatstein and SA Rosenberg
Radiation Oncology Branch, National Cancer Institute, Bethesda, MD 20892.

Between January 1980 and September 1985, 35 adult patients with resectable retroperitoneal soft tissue sarcomas were entered on a randomized trial comparing two forms of adjuvant radiation therapy. Fifteen patients received the experimental therapy consisting of intraoperative radiotherapy (IORT) to 20 Gy using high-energy electrons followed by low-dose (35 to 40 Gy) postoperative external beam irradiation. Twenty patients received standard therapy consisting of high-dose (50 to 55 Gy) postoperative external beam irradiation. With a minimum follow-up of 15 months, there is no significant difference in the actuarial disease-free survival (DFS) and overall survival (OS) comparing the two groups (median DFS, 34 months; median OS, 38 months). At 5 years follow-up, approximately 40% of patients are alive and 20% of patients remain disease-free. Although there is a trend towards an improvement in in-field local control in the experimental arm, the predominant pattern of failure in both groups was locoregional within the retroperitoneum and/or peritoneal cavity. Acute and late radiation enteritis were significantly reduced in the experimental group. However, four experimental patients developed late (greater than 6 months following treatment) peripheral neuropathy believed related to the use of IORT; all four recovered. We conclude that there is no difference in the therapeutic effectiveness of the combination of IORT and low-dose external beam radiation compared with conventional high- dose radiation as adjuvant treatment in retroperitoneal sarcomas, although the former appears to be less toxic. Newer combined modality treatment strategies are discussed to improve the prognosis in these patients.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				G. des Guetz, P. Mariani, P. Freneaux, and P. Pouillart Paraneoplastic Syndromes in Cancer: CASE 2. Leucocytosis Associated With Liposarcoma Recurrence: Original Presentation of Liposarcoma Recurrence J. Clin. Oncol., June 1, 2004; 22(11): 2242 - 2243. [Full Text] [PDF]

				S. G. Marcus, M. J. Merino, E. Glatstein, T. F. DeLaney, S. M. Steinberg, S. A. Rosenberg, and J. C. Yang Long-term Outcome in 87 Patients With Low-Grade Soft-Tissue Sarcoma Arch Surg, December 1, 1993; 128(12): 1336 - 1343. [Abstract] [PDF]

				W. F. Sindelar, T. J. Kinsella, P. W. Chen, T. F. DeLaney, J. E. Tepper, S. A. Rosenberg, and E. Glatstein Intraoperative Radiotherapy in Retroperitoneal Sarcomas: Final Results of a Prospective, Randomized, Clinical Trial Arch Surg, April 1, 1993; 128(4): 402 - 410. [Abstract] [PDF]